| Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens P Larsson, H Engqvist, J Biermann, E Werner Rönnerman, ... Scientific reports 10 (1), 1-12, 2020 | 94 | 2020 |
| Integrative genomics approach identifies molecular features associated with early-stage ovarian carcinoma histotypes H Engqvist, TZ Parris, J Biermann, EW Rönnerman, P Larsson, ... Scientific Reports 10 (1), 1-13, 2020 | 13 | 2020 |
| Pan-cancer analysis identifies BIRC5 as a prognostic biomarker A Fäldt Beding, P Larsson, K Helou, Z Einbeigi, TZ Parris BMC cancer 22 (1), 1-13, 2022 | 5 | 2022 |
| Pan-cancer analysis of genomic and transcriptomic data reveals the prognostic relevance of human proteasome genes in different cancer types P Larsson, D Pettersson, H Engqvist, E Werner Rönnerman, ... BMC cancer 22 (1), 993, 2022 | | 2022 |
| Abstract P2-06-19: The effect of UBE2C expression on intrinsic chemosensitivity in breast cancer cell lines TZ Parris, P Larsson, J Biermann, H Engqvist, E Werner-Rönnerman, ... Cancer Research 79 (4_Supplement), P2-06-19-P2-06-19, 2019 | | 2019 |
Toshima Z. ParrisAssociate Professor, University of GothenburgVerified email at oncology.gu.se
Toshima Z. ParrisAssociate Professor, University of GothenburgVerified email at oncology.gu.se